NYSE:ALL - Allstate Stock Price, News & Analysis

Allstate trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALL."

Allstate declared a quarterly dividend on Wednesday, July 17th. Investors of record on Friday, August 30th will be given a dividend of $0.50 per share on Tuesday, October 1st. This represents a $2.00 annualized dividend and a yield of 1.89%. The ex-dividend date is Thursday, August 29th. View Allstate's Dividend History.

Allstate Corp (NYSE:ALL) released its quarterly earnings results on Tuesday, July, 30th. The insurance provider reported $2.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.48 by $0.70. The insurance provider had revenue of $8.99 billion for the quarter, compared to analyst estimates of $8.96 billion. Allstate had a return on equity of 12.66% and a net margin of 6.52%. The company's revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.00 EPS. View Allstate's Earnings History.

Allstate is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Allstate.

Allstate will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

14 brokerages have issued 12-month price targets for Allstate's stock. Their forecasts range from $94.00 to $125.00. On average, they anticipate Allstate's share price to reach $108.5833 in the next twelve months. This suggests a possible upside of 2.6% from the stock's current price. View Analyst Price Targets for Allstate.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allstate in the last year. There are currently 1 sell rating, 6 hold ratings, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allstate.

News stories about ALL stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Allstate earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave media stories about the insurance provider a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Allstate.

Allstate saw a decrease in short interest in August. As of August 31st, there was short interest totalling 4,097,000 shares, a decrease of 6.1% from the July 31st total of 4,361,900 shares. Based on an average daily trading volume, of 1,540,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.3% of the company's stock are short sold. View Allstate's Current Options Chain.

Some companies that are related to Allstate include Chubb (CB), American International Group (AIG), Progressive (PGR), Travelers Companies (TRV), Tokio Marine (TKOMY), Hartford Financial Services Group (HIG), Ms&Ad Insurance Group (MSADY), Cincinnati Financial (CINF), Arch Capital Group (ACGL), Markel (MKL), Loews (L), Cna Financial (CNA), W. R. Berkley (WRB), Fairfax Financial Holdings Ltd Subordinate Voting Shares (FRFHF) and Alleghany (Y).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allstate investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), CA (CA), Micron Technology (MU), Honeywell International (HON), Athabasca Oil (ATH), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Accenture (ACN) and Allergan (AGN).

Allstate's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.99%), BlackRock Inc. (7.99%), Vanguard Group Inc. (7.50%), Boston Partners (2.90%), Northern Trust Corp (1.96%) and AQR Capital Management LLC (1.94%). Company insiders that own Allstate stock include Glenn T Shapiro, Harriet K Harty, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik, Suren Gupta, Susan L Lees and Thomas J Wilson. View Institutional Ownership Trends for Allstate.

ALL stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, APG Asset Management N.V., Morgan Stanley, Quest Capital Management Inc. ADV, First Trust Advisors LP, Point72 Asset Management L.P., Janus Henderson Group PLC and Janus Henderson Group PLC. Company insiders that have sold Allstate company stock in the last year include Glenn T Shapiro, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik and Susan L Lees. View Insider Buying and Selling for Allstate.

ALL stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Renaissance Technologies LLC, MUFG Securities EMEA plc, Invesco Ltd., Atalanta Sosnoff Capital LLC, California Public Employees Retirement System, Victory Capital Management Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Allstate.

Shares of ALL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALL stock can currently be purchased for approximately $105.81.

Allstate has a market capitalization of $34.83 billion and generates $39.82 billion in revenue each year. The insurance provider earns $2.25 billion in net income (profit) each year or $8.07 on an earnings per share basis. Allstate employs 45,700 workers across the globe.View Additional Information About Allstate.

The official website for Allstate is http://www.allstate.com/.

Allstate's mailing address is 2775 SANDERS ROAD, NORTHBROOK IL, 60062. The insurance provider can be reached via phone at 847-402-5000 or via email at [email protected]